The company will debut its new excipient portfolio, StabiliPro, at SupplySide Global 2025 in Las Vegas
The collaborations aim to accelerate the discovery of new therapeutic candidates, particularly in oncology and neurology, by combining next-generation AI platforms with...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.